Project Details
Description
Evaluation of Lenaliodomide as a Maintenance Therapy Post Allogeneic Hematopoietic Cell Transplantation for high-risk multiple Myeloma
| Status | Finished |
|---|---|
| Effective start/end date | 2/1/08 → 1/1/13 |
Funding
- NATIONAL MARROW DONOR PROGRAM
- CELGENE CORPORATION
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.